Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  January 6, 2026
Memoranda
2026 Forecast for U.S. Federal and International Chemical Regulatory Policy

Download a PDF of the Forecast 2026. Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia...

  December 29, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  January 30, 2026
Memoranda
EPA Releases Draft Pesticide Registration Notice 2026-NEW: Notifications, Non-Notifications, and Minor Formulation Amendments

On January 5, 2026, the U.S. Environmental Protection Agency (EPA) released its draft Pesticide Registration (PR) Notice, entitled “Pesticide...

  January 27, 2026
Memoranda
House Subcommittee Holds Hearing on Legislation to Modernize TSCA

The House Committee on Energy and Commerce held a hearing on January 22, 2026, on “Chemicals in Commerce: Legislative Proposal to Modernize...

  January 17, 2026
Memoranda
House Releases Discussion Draft of Legislation to Modernize TSCA

On January 15, 2026, the House Energy and Commerce Subcommittee on Environment announced it will hold a legislative hearing on January 22,...

  January 9, 2026
Memoranda
OEHHA Issues Information Letters Providing Prop 65 Guidance

In December 2025, the California Office of Environmental Health Hazard Assessment (OEHHA), the state agency responsible for implementing Proposition...

  January 7, 2026
Memoranda
EPA Publishes Final Risk Evaluation for 1,3-Butadiene, Intends to Regulate 11 COUs to Protect Workers

The U.S. Environmental Protection Agency (EPA) announced on January 5, 2026, the availability of the final risk evaluation under the Toxic Substances...

Seminars & Webinars

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

  November 6, 2025
Seminars & Webinars
Environmental Law 2026, February 19-20, 2026, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2026,” a two-day program on the latest developments across every major area of environmental law—from air,...

  December 9, 2025
Seminars & Webinars
GlobalChem, February 22-24, 2026, Washington, D.C.

GlobalChem, presented by the American Chemistry Council, brings together industry professionals to review recent developments in global chemicals...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.’s. Government affairs and regulatory specialists including four high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.